191 related articles for article (PubMed ID: 17510731)
1. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects.
Habisch HJ; Janowski M; Binder D; Kuzma-Kozakiewicz M; Widmann A; Habich A; Schwalenstöcker B; Hermann A; Brenner R; Lukomska B; Domanska-Janik K; Ludolph AC; Storch A
J Neural Transm (Vienna); 2007; 114(11):1395-406. PubMed ID: 17510731
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice.
Kim H; Kim HY; Choi MR; Hwang S; Nam KH; Kim HC; Han JS; Kim KS; Yoon HS; Kim SH
Neurosci Lett; 2010 Jan; 468(3):190-4. PubMed ID: 19879334
[TBL] [Abstract][Full Text] [Related]
3. Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis.
Zhang C; Zhou C; Teng JJ; Zhao RL; Song YQ; Zhang C
Cytotherapy; 2009; 11(3):299-306. PubMed ID: 19333801
[TBL] [Abstract][Full Text] [Related]
4. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.
Zhao CP; Zhang C; Zhou SN; Xie YM; Wang YH; Huang H; Shang YC; Li WY; Zhou C; Yu MJ; Feng SW
Cytotherapy; 2007; 9(5):414-26. PubMed ID: 17786603
[TBL] [Abstract][Full Text] [Related]
5. Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.
Srivastava AK; Gross SK; Almad AA; Bulte CA; Maragakis NJ; Bulte JWM
Exp Neurol; 2017 Mar; 289():96-102. PubMed ID: 28038988
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1
Bursch F; Rath KJ; Sarikidi A; Böselt S; Kefalakes E; Osmanovic A; Thau-Habermann N; Klöß S; Köhl U; Petri S
J Tissue Eng Regen Med; 2019 Apr; 13(4):649-663. PubMed ID: 30811816
[TBL] [Abstract][Full Text] [Related]
7. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.
Knippenberg S; Rath KJ; Böselt S; Thau-Habermann N; Schwarz SC; Dengler R; Wegner F; Petri S
J Tissue Eng Regen Med; 2017 Mar; 11(3):751-764. PubMed ID: 25641599
[TBL] [Abstract][Full Text] [Related]
8. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
[TBL] [Abstract][Full Text] [Related]
9. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis.
Vercelli A; Mereuta OM; Garbossa D; Muraca G; Mareschi K; Rustichelli D; Ferrero I; Mazzini L; Madon E; Fagioli F
Neurobiol Dis; 2008 Sep; 31(3):395-405. PubMed ID: 18586098
[TBL] [Abstract][Full Text] [Related]
10. Human marrow stromal cells reduce microglial activation to protect motor neurons in a transgenic mouse model of amyotrophic lateral sclerosis.
Zhou C; Zhang C; Zhao R; Chi S; Ge P; Zhang C
J Neuroinflammation; 2013 Apr; 10():52. PubMed ID: 23631660
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
13. Intraspinal bone-marrow cell therapy at pre- and symptomatic phases in a mouse model of amyotrophic lateral sclerosis.
Gubert F; Decotelli AB; Bonacossa-Pereira I; Figueiredo FR; Zaverucha-do-Valle C; Tovar-Moll F; Hoffmann L; Urmenyi TP; Santiago MF; Mendez-Otero R
Stem Cell Res Ther; 2016 Mar; 7():41. PubMed ID: 26979533
[TBL] [Abstract][Full Text] [Related]
14. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues.
Corti S; Locatelli F; Donadoni C; Guglieri M; Papadimitriou D; Strazzer S; Del Bo R; Comi GP
Brain; 2004 Nov; 127(Pt 11):2518-32. PubMed ID: 15469951
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of human bone marrow stem cells into symptomatic ALS mice enhances structural and functional blood-spinal cord barrier repair.
Garbuzova-Davis S; Haller E; Navarro S; Besong TE; Boccio KJ; Hailu S; Khatib M; Sanberg PR; Appel SH; Borlongan CV
Exp Neurol; 2018 Dec; 310():33-47. PubMed ID: 30172620
[TBL] [Abstract][Full Text] [Related]
16. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice.
Yan J; Xu L; Welsh AM; Chen D; Hazel T; Johe K; Koliatsos VE
Stem Cells; 2006 Aug; 24(8):1976-85. PubMed ID: 16644922
[TBL] [Abstract][Full Text] [Related]
17. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of bone marrow mononuclear cells prolongs survival, delays disease onset and progression and mitigates neuronal loss in pre-symptomatic, but not symptomatic ALS mice.
Venturin GT; Greggio S; Zanirati G; Marinowic DR; de Oliveira IM; Pêgas Henriques JA; DaCosta JC
Neurosci Lett; 2016 Oct; 633():182-188. PubMed ID: 27666978
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
20. An astrocyte regenerative response from vimentin-containing cells in the spinal cord of amyotrophic lateral sclerosis's disease-like transgenic (G93A SOD1) mice.
Zhou Y; Lu Y; Fang X; Zhang J; Li J; Li S; Deng X; Yu Y; Xu R
Neurodegener Dis; 2015; 15(1):1-12. PubMed ID: 25591625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
